The Utility of Plasma Vascular Biomarkers in Systemic Sclerosis: A Prospective Longitudinal Analysis.

Christopher A MecoliAmi A ShahFrancesco BoinFredrick M WigleyLaura K Hummers

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2020)

These data suggest that molecules involved in angiogenesis reflect vascular perturbation, and that elevations in these biomarkers at first encounter can indicate patients who are at risk of PH development.

Keyphrases

systemic sclerosis
end stage renal disease
interstitial lung disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
cross sectional
patient reported outcomes
vascular endothelial growth factor